Follow the people · Insider
Kimberly Park
Kimberly Park files insider transactions with the SEC as a director of Corcept Therapeutics (CORT). We hold 1 disclosed purchase or sale filed since 18 September 2019, 1 of them in the last 90 days.
- Files forCORT
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure28 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 17 September 2019 — 26 August 2026Director · Corcept Therapeutics (CORT)12 Form 4 lines · source: SEC Form 4
Everything they disclosed
12 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 30,000 shares of Corcept TherapeuticsSEC Form 428 August 2026Common Stock · traded 26 August 2026 · filed 28 August 2026
- had shares withheld for tax on 3,315 shares of Corcept TherapeuticsSEC Form 428 August 2026Common Stock · traded 26 August 2026 · filed 28 August 2026
- ▼ sold on the open market 26,685 shares of Corcept TherapeuticsSEC Form 428 August 2026Common Stock · traded 26 August 2026 · filed 28 August 2026
- exercised options over 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 428 August 2026Stock Option (right to buy) · traded 26 August 2026 · filed 28 August 2026
- was granted 12,500 shares of Corcept Therapeutics (a derivative holding)SEC Form 426 May 2026Stock Option (right to buy) · traded 21 May 2026 · filed 26 May 2026
- was granted 15,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 412 June 2025Stock option (right to buy) · traded 10 June 2025 · filed 12 June 2025
- was granted 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 421 May 2024Stock option (right to buy) · traded 17 May 2024 · filed 21 May 2024
- was granted 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 423 May 2023Stock option (right to buy) · traded 19 May 2023 · filed 23 May 2023
- was granted 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 42 June 2022Stock option (right to buy) · traded 31 May 2022 · filed 2 June 2022
- was granted 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 428 May 2021Stock Option (Right to Buy) · traded 26 May 2021 · filed 28 May 2021
- was granted 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 429 May 2020Stock Option (Right to Buy) · traded 27 May 2020 · filed 29 May 2020
- was granted 60,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 418 September 2019Stock Option (Right to Buy) · traded 17 September 2019 · filed 18 September 2019
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.